Valproic acid selectively suppresses the formation of inhibitory synapses in cultured cortical neurons

Neuroscience Letters

Volumn 569, Issue , 2014, Pages 142-147

  Kumamaru, Emi ^a   Egashira, Yoshihiro ^a   Takenaka, Rie ^a   Takamori, Shigeo ^a  

^a DOSHISHA UNIVERSITY   (Japan)

Author keywords

Synapse formation; Valproic acid; Vesicular GABA transporter

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; HISTONE DEACETYLASE; MICROTUBULE ASSOCIATED PROTEIN 2; SYNAPTOPHYSIN; TRICHOSTATIN A; VALPROIC ACID; VALPROMIDE; VESICULAR GLUTAMATE TRANSPORTER; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR GLUTAMATE TRANSPORTER 2; VESICULAR INHIBITORY AMINO ACID TRANSPORTER; 4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; HISTONE DEACETYLASE INHIBITOR; VIAAT PROTEIN, RAT;

ANIMAL CELL; ARTICLE; BRAIN CELL CULTURE; BRAIN DEVELOPMENT; CELL COUNT; CELL DEATH; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; IMMUNOCYTOCHEMISTRY; NERVE CELL DIFFERENTIATION; NERVE CELL NETWORK; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYNAPSE; ANIMAL; BRAIN CORTEX; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NERVE CELL; NERVE FIBER; NEWBORN; PHYSIOLOGY; TIME; ULTRASTRUCTURE;

ANIMALS; ANIMALS, NEWBORN; ANTICONVULSANTS; AXONS; CELLS, CULTURED; CEREBRAL CORTEX; GAMMA-AMINOBUTYRIC ACID; HISTONE DEACETYLASE INHIBITORS; NEURONS; RATS; SYNAPSES; TIME FACTORS; VALPROIC ACID; VESICULAR INHIBITORY AMINO ACID TRANSPORT PROTEINS;

EID: 84898958933     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.03.066     Document Type: Article

References (35)

1. LeBlanc J.J., Fagiolini M. Autism: a "critical period" disorder?. Neural Plast. 2011, 2011:921680.
2. Ramamoorthi K., Lin Y. The contribution of GABAergic dysfunction to neurodevelopmental disorders. Trends Mol. Med. 2011, 17:452-462.
3. Akerman C.J., Cline H.T. Refining the roles of GABAergic signaling during neural circuit formation. Trends Neurosci. 2007, 30:382-389.
4. Lewis D.A., Gonzalez-Burgos G. Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 2008, 33:141-165.
5. McCormick D.A., Contreras D. On the cellular and network bases of epileptic seizures. Annu. Rev. Physiol. 2001, 63:815-846.
6. Chao H.T., Chen H., Samaco R.C., Xue M., Chahrour M., Yoo J., Neul J.L., Gong S., Lu H.C., Heintz N., Ekker M., Rubenstein J.L., Noebels J.L., Rosenmund C., Zoghbi H.Y. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010, 468:263-269.
7. Chubykin A.A., Atasoy D., Etherton M.R., Brose N., Kavalali E.T., Gibson J.R., Südhof T.C. Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Neuron 2007, 54:919-931.
8. Collins R.M., Zielke H.R., Woody R.C. Valproate increases glutaminase and decreases glutamine synthetase activities in primary cultures of rat brain astrocytes. J. Neurochem. 1994, 62:1137-1143.
9. Larsson O.M., Gram L., Schousboe I., Schousboe A. Differential effect of gamma-vinyl GABA and valproate on GABA-transaminase from cultured neurones and astrocytes. Neuropharmacology 1986, 25:617-625.
10. Ornoy A. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?. Reprod. Toxicol. 2009, 28:1-10.
11. Rasalam A.D., Hailey H., Williams J.H., Moore S.J., Turnpenny P.D., Lloyd D.J., Dean J.C. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev. Med. Child. Neurol. 2005, 47:551-555.
12. Williams G., King J., Cunningham M., Stephan M., Kerr B., Hersh J.H. Fetal valproate syndrome and autism: additional evidence of an association. Dev. Med. Child. Neurol. 2001, 43:202-206.
13. Christianson A.L., Chesler N., Kromberg J.G. Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs. Dev. Med. Child. Neurol. 1994, 36:361-369.
14. Markram K., Rinaldi T., La Mendola D., Sandi C., Markram H. Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology 2008, 33:901-912.
15. Rinaldi T., Silberberg G., Markram H. Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid. Cereb. Cortex. 2008, 18:763-770.
16. Yochum C.L., Dowling P., Reuhl K.R., Wagner G.C., Ming X. VPA-induced apoptosis and behavioral deficits in neonatal mice. Brain. Res. 2008, 1203:126-132.
17. Wagner G.C., Reuhl K.R., Cheh M., McRae P., Halladay A.K. A new neurobehavioral model of autism in mice: pre- and postnatal exposure to sodium valproate. J. Autism Dev. Disord. 2006, 36:779-793.
18. Coyle J.T., Duman R.S. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 2003, 38:157-160.
19. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., Klein P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 2001, 276:36734-36741.
20. Hao Y., Creson T., Zhang L., Li P., Du F., Yuan P., Gould T.D., Manji H.K., Chen G. Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J. Neurosci. 2004, 24:6590-6599.
21. Hsieh J., Nakashima K., Kuwabara T., Mejia E., Gage F.H. Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:16659-16664.
22. Fukuchi M., Nii T., Ishimaru N., Minamino A., Hara D., Takasaki I., Tabuchi A., Tsuda M. Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions. Neurosci. Res. 2009, 65:35-43.
23. Gottmann K., Mittmann T., Lessmann V. BDNF signaling in the formation, maturation and plasticity of glutamatergic and GABAergic synapses. Exp. Brain. Res. 2009, 199:203-234.
24. Numakawa T., Yamagish S., Adachi N., Matsumoto T., Yokomaku D., Yamada M., Hatanaka H. Brain-derived neurotrophic factor-induced potentiation of Ca(2+) oscillations in developing cortical neurons. J. Biol. Chem. 2002, 277:6520-6529.
25. Takamori S., Riedel D., Jahn R. Immunoisolation of GABA-specific synaptic vesicles defines a functionally distinct subset of synaptic vesicles. J. Neurosci. 2000, 20:4904-4911.
26. Takamori S., Rhee J.S., Rosenmund C., Jahn R. Identification of differentiation-associated brain-specific phosphate transporter as a second vesicular glutamate transporter (VGLUT2). J. Neurosci. 2001, 21:RC182.
27. De Gois S., Schafer M.K., Defamie N., Chen C., Ricci A., Weihe E., Varoqui H., Erickson J.D. Homeostatic scaling of vesicular glutamate and GABA transporter expression in rat neocortical circuits. J. Neurosci. 2005, 25:7121-7133.
28. Cowan W.M., Südhof T.C., Stevens C.F., Synapses Synapse formation and Maturation 2001, 571-612. The Johns Hopkins University Press, Baltimore, Maryland, U.S.A.
29. Banerjee A., Garcia-Oscos F., Roychowdhury S., Galindo L.C., Hall S., Kilgard M.P., Atzori M. Impairment of cortical GABAergic synaptic transmission in an environmental rat model of autism. Inter. J. Neuropsychopharmacol. 2013, 16:1309-1318.
30. Ben-Ari Y. Basic developmental rules and their implications for epilepsy in the immature brain. Epileptic. Disord. 2006, 8:91-102.
31. Deng L., Yao J., Fang C., Dong N., Luscher B., Chen G. Sequential postsynaptic maturation governs the temporal order of GABAergic and glutamatergic synaptogenesis in rat embryonic cultures. J.Neurosci. 2007, 27:10860-10869.
32. Hensch T.K. Critical period plasticity in local cortical circuits. Nat. Rev. Neurosci. 2005, 6:877-888.
33. Huang Z.J. Activity-dependent development of inhibitory synapses and innervation pattern: role of GABA signalling and beyond. J. Physiol. 2009, 587:1881-1888.
34. Moldrich R.X., Leanage G., She D., Dolan-Evans E., Nelson M., Reza N., Reutens D.C. Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice. Behav. Brain. Res. 2013, 257:253-264.
35. Kataoka S., Takuma K., Hara Y., Maeda Y., Ago Y., Matsuda T. Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. Int. J. Neuropsychopharmacol. 2013, 16:91-103.